Research Blog & News
Congratulations to Alessa!
At our 2nd FerrOs Retreat Alessa Wagner was awarded with our „Back To Science” Grant to join the lab of Prof. Maja Vujic-Spasic in Ulm after her maternal leave.
Second FerrOs Retreat: Finally, the whole FerrOs team got together in person!
On June 29th – July 1st we met in Riederau at the Ammersee at our 2nd FerrOs Retreat. Since we were not able to meet face-to-face at our 1st retreat, we were all more than happy to get together in real life and listen to the presentations of our eight FerrOs projects.
April 23 is International FOP Awareness Day 2022!!
Since the University of Pennsylvania announced their breakthrough discovery of the FOP gene ACVR1 at April 23, 2006, this date is now celebrated as International FOP Awareness Day! This year marks the 16th anniversary of the discovery of the FOP gene meaning 16 years of hope, progress and determination to find a cure.
Congratulations to Andrea Burden, Ph.D., Recipient of the 2021 Emerging Leader in Pharmaceutical Sciences
The Leslie Dan Faculty of Pharmacy from University of Toronto, Canada, awarded six Alumni Awards (https://www.pharmacy.utoronto.ca/news-announcements/exceptional-alumni-recognized-through-second-annual-alumni-awards) in different categories recognizing the remarkable achievements of alumni in pharmacy practice and pharmaceutical sciences.
New publication by FerrOs researchers!
We proudly present the new article by Silvia Colucci, Sandro Altamura and Martina Muckenthaler from our FerrOs Research Group on "Liver Sinusoidal Endothelial Cells Suppress Bone Morphogenetic Protein 2 Production in Response to TGFβ Pathway Activation" that was just published in Hepatology (https://pubmed.ncbi.nlm.nih.gov/33982327/).
2nd FerrOs Webinar: Delphine Meynard on Matriptase-2 as a therapeutic target
Our second FerrOs Webinar took place on September 28th. The FerrOs members were very keen on listening to the excellent talk of Delphine Meynard, who presented her newest work on the role of matripase-2 as a novel therapeutic target in diseases with ineffective hematopoiesis. Besides the stimulating talk, it was great to see each other again and get to know new members of the FerrOs consortium.